Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
Journal of Cellular and Molecular Medicine · 2024-01 · 28 (2)
DOI: 10.1111/jcmm.18055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 19.12.2023. Verfasst von Chennian Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of …. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental, Triterpenes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, General Program of China Postdoctoral Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a chronic microvascular complication of diabetes that is generally defined as ventricular dysfunction occurring in patients with diabetes and unrelated to known causes. Several mechanisms have been proposed to contribute to the occurrence and persistence of DCM, in which oxidative stress and autophagy play a non‐negligible role. Diabetic cardiomyopathy is involved in a variety of physiological and pathological processes. The 5′ adenosine monophosphate‐activated protein kinase/nuclear factor‐erythroid 2‐related factor 2 (AMPK/Nrf2) are expressed in the heart, and studies have shown that asiaticoside (ASI) and activated AMPK/Nrf2 have a protective effect on the myocardium. However, the roles of ASI and AMPK/Nrf2 in DCM are unknown. The intraperitoneal injection of streptozotocin (STZ) and high‐fat feed were used to establish the DCM models in 100 C57/BL mice. Asiaticoside and inhibitors of AMPK/Nrf2 were used for intervention. Cardiac function, oxidative stress, and autophagy were measured in mice. DCM mice displayed increased levels of oxidative stress while autophagy levels declined. In addition, AMPK/Nrf2 was activated in DCM mice with ASI intervention. Further, we discovered that AMPK/Nrf2 inhibition blocked the protective effect of ASI by compound C and treatment with ML‐385. The present study demonstrates that ASI exerts a protective effect against DCM via the potential activation of the AMPK/Nrf2 pathway. Asiaticoside is a potential therapeutic target for DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Air Force Medical University, Xi'an,…
- Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
- Department of Cardiovascular Surgery, General Hospital of Northern Theatre Command, Shenyang, Liaoning, China.
- School of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, China.
- Department of Cardiothoracic Surgery, The 79th Group Military Hospital of the Chinese People's Liberation Army, Liaoyang, Liaoning Province, China.
- Department of Anesthesiology, Xi'an Children's Hospital, Xi'an, Shaanxi, China.
ORCID-Profile: Chennian Xu
Förderung
- National Natural Science Foundation of China
- General Program of China Postdoctoral Science Foundation
- National Key Research and Development Program of China
- Shaanxi Provincial Fund for Distinguished Young Scholars
- Shaanxi Provincial Key Research and Development Plan
- The first batch of science and technology development funds on central guidance for local development in Liaoning Province in 2023
Zitieren
APA
Xu, C., Xia, L., Xu, D., Liu, Y., Jin, P., Zhai, M., Mao, Y., Wang, Y., Wen, A., Yang, J., & Yang, L. (2024). Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway. Journal of Cellular and Molecular Medicine, 28(2). https://doi.org/10.1111/jcmm.18055
Vancouver
Xu C, Xia L, Xu D, Liu Y, Jin P, Zhai M, et al. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway. Journal of Cellular and Molecular Medicine. 2024;28(2). doi:10.1111/jcmm.18055
BibTeX
@article{Xu2024,
author = {Xu, Chennian and Xia, Lin and Xu, Dengyue and Liu, Yang and Jin, Ping and Zhai, Mengen and Mao, Yu and Wang, Yiwei and Wen, Anguo and Yang, Jian and Yang, Lifang},
title = {Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {2},
doi = {10.1111/jcmm.18055}
}
EUVIMED